About Office of Industrial Base Management and Supply Chain

The IBMSC was established when the COVID-19 pandemic demonstrated the importance of a robust and resilient public health industrial base to national health security.  Now a permanent capability within ASPR, IBMSC is charged with enhancing preparedness by building a resilient domestic public health industrial base and developing innovative solutions to address critical deficiencies in the public health supply chain.

The IBMSC is working to build a diverse, agile public health supply chain and sustain long-term U.S. manufacturing capabilities by investing in medical product Industrial Base Expansion (IBx) capacities that can enable ASPR to respond to future public health emergencies. 

IBMSC coordinates  domestic industrial base expansion efforts for medical products  across ASPR, federal partners, academia, and the private sector to operationalize novel solutions and practices for response and recovery operations by:

• Promoting multi-functional capabilities, including advanced manufacturing and supply chain optimization, that ensure relevant stakeholders can access necessary raw materials and components needed for domestic manufacturing.
• Establishing innovative domestic industrial base programs and enduring, sustainable partnerships across the medical countermeasure ecosystem including with biotech, pharma, distributors, healthcare, non-profit, and for-profit organizations; and
• Sustaining critical medical countermeasures and public health supply advancement and capacity while prioritizing long-term, viable, adaptable domestic industrial base infrastructure to sustain commercial markets, partnerships, and life-cycle supply chain management.